1 of 15

HIV Response Sustainability Assessment�2024��Sustaining the HIV Response for the Long Term

Proposed High Level Outcomes for a Sustainable HIV Response

2 of 15

Context: Uganda made significant progress in reducing new HIV infections & AIDS mortality in recent years, but meeting 2030 targets is contingent on bending the epidemic curve significantly during 2023-30

3 of 15

Rationale for Long-term HIV Programme Sustainability

  • Currently there over 1.4 million PLHIVs who are receiving ART, that will live health and productive lives for several decades to come
  • However, If we don’t meet the 2030 targets and more new HIV infections occur, the number of PLHIV will be higher as shown in the blue bars
  • That is why we need to meet our 2030 targets and sustain the gains for decades to come

4 of 15

Risks of Not Sustaining Gains ……….

  • Continued reduction of new HIV infections will be necessary after 2030 through sustained HIV prevention for the general population services

  • Not sustaining efforts could lead to a second wave as shown in the blue curve which forecasts new infections if condom use dropped by 50% during 2030 – 35, up to 40,000 additional infections could occur during 2030 – 50. Reversal in other interventions could result in more pronounced spikes

5 of 15

Declining HIV Resources Amidst Low Domestic Funding and Restricted Fiscal Space and HIV Funding Gap of approx. 25% in 2023

6 of 15

HIV Response Sustainability �

the state where Uganda is able to maintain and increase HIV programme performance and health outcomes for people living with, affected or at risk of HIV for decades to come, delivered within the broader national financial, political, legal, social and health ecosystems in the country

7 of 15

The Response Sustainability Assessment

  • As part of developing the HIV response sustainability roadmap, we assessed the sustainability of the response across five domains, which are further divided into 21 sub-domains – across 125 programme elements
    • Political Leadership
    • Enabling environment and policies
    • Services and Solutions
    • Sustainable and Equitable Financing
    • Systems
  • The structured participatory assessment was conducted in July – August 2024 based on the UNAIDS tool
  • Following that, stakeholders have agreed on HLOs to be achieved in order to sustain the HIV response for the long term
  • We now present the draft High Level Outcomes

8 of 15

High Level Outcomes

Increased domestic funding for EMHS of UGX 200 billion annually .

    • Increase in domestic funding for ART from USD $ 62 M to USD $ 135 M by 2030.
    • Increase in domestic funding to meet 50% of the cost of Co infection drugs by 2030

Lowered unit cost of production of locally manufactured ARTs from 18$ per ARV patient to 11$ per ARV patient.

High coverage of new cost effective interventions ( Injectable ART, DSDM, SMC)

Pathways of Change

  • High level advocacy for increased funding for EMHS & ARTs + tracking of the funding ,
  • Traceability & visibility of ARTs bought through different funding streams.

  • Lower cost of production of ART, negotiate for regional market, get FDA approval.
  • Feasibility studies for new technologies , mobilization of resources , targeted implementation of new technologies, phased uptake of injectable ART,
  • Regular review of treatment algorithms , service delivery models.

Health Technologies

9 of 15

�High level Outcomes

  • Harmonized procurement of supplies and commodities guided by the PPDA by 2030
  • Functional electronic integrated logistics information management system in 80% of health centre III facilities by 2030
  • Increased 95% availability of
  • a basket of 41 tracer commodities from 78% in 2021/2022 to 85% by 2030
  • ARVs from 81% in 2021/2022 to 85% by 2030
  • Wastage of drugs and supplies reduced by 5 % by 2030.

Pathways of Change

  • High level negotiations with partners for joint procurement.
  • Review of PPDA to identify and address bottlenecks
  • Funding for expanding LMIS infrastructure, upskilling of HW.
  • Increased funding for EMHS, adequate district regional warehouses, upskilling of HSC staff, tracebility & visibility of commodities, recruitment of pharmacists, continuous supervision by pharmacists to curb irrational transcribing

Procurement & Supply Chain

10 of 15

High level Outcomes

  • Increased recruitment & upskilling of lab personnel.
  • LMIS system that is integrated with the HMIS & EMR in 80% of HC III’s by 2030
  • Increased funding & more efficient use of lab resources
    • Increased GoU funding for reagents and equipment and operations by 2030
    • Harmonized use of lab resources ( equipment , personnel)
    • Unified sourcing system for lab commodities by 2030
  • 50 % of laboratories accredited.

Pathways of Change

  • Expanding capacity – adequate personnel with appropriate skills, fully equipped labs with required commodities, internet, computers upskilling of HWs - a roadmap for expansion with targets, costs, implementation plan
  • Interoperable systems – LMIS & EMR& HMIS
  • Efficient systems – harmonized procurement & implementation – review of PPDA, negotiation with partners , PPP to promote efficient use of expensive equipment and under used equipment
  • Quality services – Streamlined Governance and leadership, Expand National & international accreditation, functional QA/QC systems in all facilities

Laboratory Systems

11 of 15

Options for increasing fiscal space

  • Budget re-prioritization -an increase in the health sector's share of the government budget to 10% or 12% or 15% - an additional USD 2.66 Billion, USD 3.79 Billion and USD 7.07 Billion, by 2030.
  • Private wings of public hospitals with improved governance and management - UGX 32 Billion (USD 8.5 Million) annually from all the NRHs, RRHs, GHs, and Specialized hospitals (USAID/UHSS Activity)
  • if partly retained e.g 50% could be a major source of revenue.

Other Financing mechanisms

  • Debt to health swaps, blended financing, bonds for health, trust funds

  • Sin taxes. A 10% increase in taxes on cigarettes, alcohol, and sugary beverages is estimated to generate nearly USD 100 million per year, which could be earmarked for the health sector.
  • Motor third party insurance. An average of UGX 2.9 Billion (USD 773,333) is projected as potential revenue per annum through MTPL premiums alone over the period FY2022/2023 to FY2026/2027, if a MTPL guarantee fund were to be established some of this could be earmarked for health
  • Improving the efficiency of health spending - annual savings of around USD 60 million ( 12.8% of public expenditure) at current spending levels (estimated to be USD 360 million between 2024/25 and 2029/30).

12 of 15

High Level Outcomes to be achieved for a Sustainable Response

Sustainable and Equitable Financing

  1. Increased domestic resources with a tax to GDP ratio of 15% by 2030.
  2. Increased Government financing from innovative financing sources and other non tax revenue from 8% of total government revenue to 15% by 2030.
  3. Increased Govt domestic allocations for health and HIV to progressively attain the 15% Abuja Declaration target
  4. Current development partner contributions to the HIV response maintained at (80%) in the short term (2030) and scaled down gradually to cover 50% of the funds required for the response in the long term (2040).
  5. Atleast 80% of development partner funds for health channelled through on budget support or virtual pool
  6. Increased efficient and effective use of resources to enable the saving of US$ 60 million annually .

13 of 15

High Level Outcomes to be achieved for a Sustainable Response

 

Sustainable financing

systems

  1. Effective social accountability systems at national and subnational levels by 2030
  2. Enhanced capacity for financial management at higher level health facilities (RRH, hospitals and HC IVs)
  3. Efficient tax administration system
  4. Effective system for virtual pooling development partner funds

14 of 15

Pathways of Change

  • Investment case analysis for increased investment in health as an investment good - priority focus on high impact interventions & reducing high DX burden through health prevention & promotion
  • High level advocacy & evidence based negotiations between MoH & MoFPED & Devt partners
  • Expanded capacity to implement &monitor - blended financing & private sector funding
  • Implementation & monitoring of other financing initiatives – NHIS, SIN taxes
  • Enhanced Tax administration
  • Debt restructuring & reduced borrowing
  • Long term commitments on donor & GOU funds +timely tracking of commitments
  • Implementation framework for virtual pooling of development partner funds
  • Harmonized procurement –drugs, supplies, equip.

15 of 15

Next Steps

  • Rationalise and sequence the HLOs taking into account overlaps, feasibility, time sequencing and cost.
  • Develop HIV Sustainability Roadmap
  • Submit Sustainability Roadmap for approval by JSC
  • Policy Dialogue